Webinars offer a variety of presentations from worldwide experts in the field of Biosimilars.

Biosimilars: Payer and Formulary Considerations

Ross M. Miller, MD, MPH, FACPERoss M. Miller, MD, MPH, FACPE
Medical Advisor
California Department of Health Care Services
Los Angeles, California
 
 


Clinician and Payer Perspectives on the First Biosimilar Approved in the US

 

Gary H. Lyman, MD, MPHGary H. Lyman, MD, MPH
Co-Director
Hutchinson Institute for Cancer Outcomes Research
Professor of Medicine
University of Washington

 

Edmund J. Pezalla, MD, MPHEdmund J. Pezalla, MD, MPH
Vice President
Pharmaceutical Policy and Strategy
Aetna
Hartford, Connecticut


CME/CE Multimedia Modules

Welcome to Biologics and Biosimilars: Preparing for the Future!

This is a series of 8 interactive modules. Each module focuses on a different topic and answers questions clinicians commonly ask about biosimilars. It is highly recommended that you complete the entire curriculum.

Module 7
Module 5
Module 6
Module 3
Module 4
Module 2
Module 1
Module 8

Comprehensive Review of Biosimilars vs. Reference Biologics

jonathan kayJonathan Kay, MD
Director of Clinical Research
Rheumatology Division
UMASS Memorial Medical Center
Professor of Medicine
University of Massachusetts Medical School
Worcester, Massachusetts
 


Preparing for the Wave of Biosimilars IQ Test

 

Priscilla Hollander, MDPriscilla Hollander, MD
Department of Endocrinology
Baylor Endocrine Center
Dallas, Texas

 

Craig W. Spellman, DO, PhDCraig W. Spellman, DO, PhD
Professor
Associate Dean Research
Director, Regional Office Clinical Trails
Texas Tech University Health Science Center
Odessa, Texas


The Fundamentals of Biosimilar Regulation and Development in the US

edward  liEdward Li, PharmD, MPH, BCOP
Associate Professor
University of New England College of Pharmacy
Portland, Maine
 


New & Noteworthy